Yvonne Dréano

3.2k total citations
59 papers, 2.7k citations indexed

About

Yvonne Dréano is a scholar working on Pharmacology, Biochemistry and Molecular Biology. According to data from OpenAlex, Yvonne Dréano has authored 59 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Pharmacology, 24 papers in Biochemistry and 13 papers in Molecular Biology. Recurrent topics in Yvonne Dréano's work include Pharmacogenetics and Drug Metabolism (37 papers), Eicosanoids and Hypertension Pharmacology (21 papers) and Drug Transport and Resistance Mechanisms (11 papers). Yvonne Dréano is often cited by papers focused on Pharmacogenetics and Drug Metabolism (37 papers), Eicosanoids and Hypertension Pharmacology (21 papers) and Drug Transport and Resistance Mechanisms (11 papers). Yvonne Dréano collaborates with scholars based in France, Germany and Belgium. Yvonne Dréano's co-authors include F. Berthou, Danièle Lucas, Philippe Beaune, D. Picart, Yolande Amet, J.F. Ménez, C. Riché, Laurent Corcos, Maude Fer and Jean‐François Ménez and has published in prestigious journals such as Circulation, Biochemical and Biophysical Research Communications and FEBS Letters.

In The Last Decade

Yvonne Dréano

58 papers receiving 2.6k citations

Peers

Yvonne Dréano
F. Berthou France
Terry V. Zenser United States
Jordan L. Holtzman United States
J. Noordhoek Netherlands
Kan He United States
Donald S. Davies United Kingdom
J. B. Watkins United States
F. Berthou France
Yvonne Dréano
Citations per year, relative to Yvonne Dréano Yvonne Dréano (= 1×) peers F. Berthou

Countries citing papers authored by Yvonne Dréano

Since Specialization
Citations

This map shows the geographic impact of Yvonne Dréano's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yvonne Dréano with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yvonne Dréano more than expected).

Fields of papers citing papers by Yvonne Dréano

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yvonne Dréano. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yvonne Dréano. The network helps show where Yvonne Dréano may publish in the future.

Co-authorship network of co-authors of Yvonne Dréano

This figure shows the co-authorship network connecting the top 25 collaborators of Yvonne Dréano. A scholar is included among the top collaborators of Yvonne Dréano based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yvonne Dréano. Yvonne Dréano is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Guriec, Nathalie, Catherine Le Jossic-Corcos, Brigitte Simon, et al.. (2014). The arachidonic acid–LTB4–BLT2 pathway enhances human B-CLL aggressiveness. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1842(11). 2096–2105. 21 indexed citations
2.
Corcos, Laurent, Danièle Lucas, Catherine Le Jossic-Corcos, et al.. (2012). Human cytochrome P450 4F3: structure, functions, and prospects. Drug metabolism and drug interactions. 27(2). 63–71. 26 indexed citations
3.
Bellien, Jérémy, Lionel Nicol, Danièle Lucas, et al.. (2011). Soluble epoxide hydrolase inhibition improves myocardial perfusion and function in experimental heart failure. Journal of Molecular and Cellular Cardiology. 52(3). 660–666. 54 indexed citations
4.
Geay, Florian, Charlotte Corporeau, Pierre Boudry, et al.. (2010). Regulation of FADS2 expression and activity in European sea bass (Dicentrarchus labrax, L.) fed a vegetable diet. Comparative Biochemistry and Physiology Part B Biochemistry and Molecular Biology. 156(4). 237–243. 74 indexed citations
5.
Lucas, Danièle, Sophie Goulitquer, Jan Marienhagen, et al.. (2009). Stereoselective epoxidation of the last double bond of polyunsaturated fatty acids by human cytochromes P450. Journal of Lipid Research. 51(5). 1125–1133. 63 indexed citations
6.
Antoun, Joseph, Sophie Goulitquer, Yolande Amet, et al.. (2008). CYP4F3B is induced by PGA1 in human liver cells: a regulation of the 20-HETE synthesis. Journal of Lipid Research. 49(10). 2135–2141. 22 indexed citations
7.
Fer, Maude, Sophie Goulitquer, Yvonne Dréano, et al.. (2006). Determination of polyunsatured fatty acid monoepoxides by high performance liquid chromatography–mass spectrometry. Journal of Chromatography A. 1115(1-2). 1–7. 18 indexed citations
9.
Lucas, Danièle, et al.. (1998). Effect of Pyrazole and Dexamethasone Administration on Cytochrome P450 2E1 and 3A Isoforms in Rat Liver and Kidney: Lack of Specificity of p‐Nitrophenol as a Substrate of P450 2E1. Alcoholism Clinical and Experimental Research. 22(3). 652–657. 17 indexed citations
10.
Amet, Yolande, et al.. (1997). Noninvolvement of CYP2E1 in the (ω-1)-hydroxylation of fatty acids in rat kidney microsomes. Biochemical Pharmacology. 54(8). 947–952. 11 indexed citations
11.
Bellec, Gwénaëlle, J.-M. Cauvin, Yvonne Dréano, et al.. (1996). Analysis of N-nitrosamines by high-performance liquid chromatography with post-column photohydrolysis and colorimetric detection. Journal of Chromatography A. 727(1). 83–92. 31 indexed citations
12.
Bellec, Gwénaëlle, Yvonne Dréano, P Lozac’h, J.F. Ménez, & F. Berthou. (1996). Cytochrome P450 metabolic dealkylation of nine N-nitrosodialkylamines by human livermicrosomes. Carcinogenesis. 17(9). 2029–2034. 66 indexed citations
13.
Amet, Yolande, et al.. (1995). Validation of the (ω-l)-hydroxylation of lauric acid as an in vitro substrate probe for human liver CYP2E1. Biochemical Pharmacology. 50(11). 1775–1782. 35 indexed citations
14.
Goasduff, Thierry, J.F. Ménez, Yvonne Dréano, & F. Berthou. (1995). CYP1A2 and 2E1 Expression in Rat Liver Treated with Combined Inducers (3-Methylcholanthrene and Ethanol). Biochemical and Biophysical Research Communications. 211(2). 497–503. 11 indexed citations
15.
Berthou, F., et al.. (1994). Involvement of cytochrome P450 3A enzyme family in the major metabolic pathways of toremifene in human liver microsomes. Biochemical Pharmacology. 47(10). 1883–1895. 75 indexed citations
16.
Berthou, F. & Yvonne Dréano. (1993). High-performance liquid chromatographic analysis of tamoxifen, toremifene and their major human metabolites. Journal of Chromatography B Biomedical Sciences and Applications. 616(1). 117–127. 29 indexed citations
17.
Lucas, Danièle, et al.. (1993). Comparison of Levels of Cytochromes P‐450, CYP1A2, CYP2E1, and Their Related Monooxygenase Activities in Human Surgical Liver Samples. Alcoholism Clinical and Experimental Research. 17(4). 900–905. 57 indexed citations
18.
Berthou, F., B. Guillois, C. Riché, et al.. (1992). Interspecies variations in caffeine metabolism related to cytochrome P4501A enzymes. Xenobiotica. 22(6). 671–680. 101 indexed citations
19.
Dréano, Yvonne, et al.. (1991). Identification of the cytochrome P450 IIIA family as the enzymes involved in the N-demethylation of tamoxifen in human liver microsomes. Biochemical Pharmacology. 41(12). 1911–1919. 162 indexed citations
20.
Berthou, F., et al.. (1982). [Specificity of methods for theophylline in biological samples: therapeutic consequences (author's transl)].. PubMed. 37(1). 53–64. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026